Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack ...

In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs ...

Beta-blocker use did not result in a lower incidence of composite death or new AMI, all-cause death, AMI, or heart failure ...

In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM). He then reviews the diagnosis and management of Kawasaki Disease. Finally, Dr. Eagle ...

Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve ...

Previously used pacemakers reconditioned with an U.S. Food and Drug Administration-approved protocol worked as well as new devices at 90 days, based on findings from the My Heart Your Heart (MHYH) ...

Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrial fibrillation (AFib) within three months after bioprosthetic ...

Norland K, Schaid DJ, Naderian M, Na J, Kullo IJ.

Keywords: American Heart Association, AHA Annual Scientific Sessions, AHA24Slides, Visual Abstract ...

The U.S. Food and Drug Administration (FDA) posted a letter to health care providers on Nov. 15, announcing that Getinge/Maquet has issued an Urgent Medical Device Removal notice warning against use ...

Three dual combinations of hypertension medications in one polypill – amlodipine and perindopril; perindopril and indapamide; or amlodipine and indapamide – were equally effective in reducing blood ...

Sudden cardiac death (SCD) in obesity is the focus of a JACC: State-of-the-Art review of the mechanisms as well as current evidence for its management, gaps in knowledge and future research, published ...